tiprankstipranks
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
Australian Market
Want to see AU:ARX full AI Analyst Report?

Aroa Biosurgery Ltd (ARX) Ratios

61 Followers

Aroa Biosurgery Ltd Ratios

AU:ARX's free cash flow for Q2 2026 was AU$0.86. For the 2026 fiscal year, AU:ARX's free cash flow was decreased by AU$ and operating cash flow was AU$-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
6.52 6.62 7.26 9.88 11.90
Quick Ratio
5.74 5.81 6.40 9.27 11.31
Cash Ratio
1.00 0.78 1.21 1.21 0.92
Solvency Ratio
0.16 0.07 -0.46 0.24 -0.43
Operating Cash Flow Ratio
0.63 -0.25 -0.78 -0.48 -1.74
Short-Term Operating Cash Flow Coverage
5.11 0.00 0.00 -6.76 -19.91
Net Current Asset Value
AU$ 45.26MAU$ 47.61MAU$ 48.54MAU$ 59.44MAU$ 62.94M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.06 0.07 0.06 0.05
Debt-to-Equity Ratio
0.08 0.07 0.08 0.07 0.06
Debt-to-Capital Ratio
0.07 0.06 0.07 0.07 0.06
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.17 1.17 1.14 1.12
Debt Service Coverage Ratio
1.88 4.86 -5.99 0.78 -2.37
Interest Coverage Ratio
0.10 -18.49 -8.41 -8.45 -6.44
Debt to Market Cap
<0.01 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
0.02 0.02 0.02 0.02 0.02
Net Debt to EBITDA
-0.59 -0.54 0.55 -3.33 0.07
Profitability Margins
Gross Profit Margin
85.47%85.73%85.39%84.40%76.37%
EBIT Margin
1.29%-2.40%-16.92%-4.91%-18.17%
EBITDA Margin
6.15%3.44%-10.71%1.15%-10.16%
Operating Profit Margin
0.16%-10.56%-15.45%-4.91%-18.93%
Pretax Profit Margin
-1.53%-3.84%-15.10%-0.61%-20.82%
Net Profit Margin
-2.02%-4.50%-15.39%-0.62%-21.13%
Continuous Operations Profit Margin
-2.02%-4.50%-15.39%-0.62%-21.06%
Net Income Per EBT
131.84%117.32%101.93%103.13%101.51%
EBT Per EBIT
-951.15%36.34%97.71%12.35%109.99%
Return on Assets (ROA)
-1.74%-3.50%-9.57%-0.34%-7.44%
Return on Equity (ROE)
-2.00%-4.10%-11.19%-0.39%-8.35%
Return on Capital Employed (ROCE)
0.15%-9.07%-10.51%-2.86%-7.09%
Return on Invested Capital (ROIC)
0.15%-8.97%-10.40%-2.83%-7.01%
Return on Tangible Assets
-2.11%-4.25%-11.63%-0.40%-8.79%
Earnings Yield
-0.89%-2.36%-5.06%-0.10%-2.94%
Efficiency Ratios
Receivables Turnover
2.70 5.19 2.63 4.42 2.32
Payables Turnover
3.20 7.25 5.91 47.73 7.03
Inventory Turnover
1.69 1.46 1.25 2.05 2.36
Fixed Asset Turnover
4.33 3.94 3.11 3.07 2.58
Asset Turnover
0.86 0.78 0.62 0.54 0.35
Working Capital Turnover Ratio
1.60 1.44 1.05 0.89 0.75
Cash Conversion Cycle
237.23 269.85 369.99 253.30 260.46
Days of Sales Outstanding
135.12 70.36 138.85 82.55 157.38
Days of Inventory Outstanding
216.34 249.82 292.91 178.40 154.96
Days of Payables Outstanding
114.24 50.33 61.77 7.65 51.89
Operating Cycle
351.47 320.18 431.76 260.95 312.34
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 >-0.01 -0.02 -0.01 -0.03
Free Cash Flow Per Share
0.01 -0.02 -0.03 -0.03 -0.04
CapEx Per Share
<0.01 <0.01 <0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
0.80 2.44 1.48 3.02 1.42
Dividend Paid and CapEx Coverage Ratio
5.07 -0.69 -2.09 -0.50 -2.40
Capital Expenditure Coverage Ratio
5.07 -0.69 -2.09 -0.50 -2.40
Operating Cash Flow Coverage Ratio
0.93 -0.40 -0.99 -0.53 -1.99
Operating Cash Flow to Sales Ratio
0.07 -0.03 -0.11 -0.06 -0.29
Free Cash Flow Yield
2.46%-3.88%-5.19%-2.96%-5.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-114.18 -42.30 -19.75 -971.35 -34.02
Price-to-Sales (P/S) Ratio
2.31 1.90 3.04 6.07 7.19
Price-to-Book (P/B) Ratio
2.34 1.73 2.21 3.78 2.84
Price-to-Free Cash Flow (P/FCF) Ratio
41.35 -25.75 -19.26 -33.79 -17.23
Price-to-Operating Cash Flow Ratio
33.11 -62.86 -28.46 -101.98 -24.42
Price-to-Earnings Growth (PEG) Ratio
-0.88 0.65 >-0.01 10.21 0.56
Price-to-Fair Value
2.34 1.73 2.21 3.78 2.84
Enterprise Value Multiple
36.98 54.85 -27.83 523.14 -70.67
Enterprise Value
183.78M 145.15M 188.79M 357.79M 264.91M
EV to EBITDA
36.30 54.85 -27.83 523.14 -70.67
EV to Sales
2.23 1.89 2.98 6.03 7.18
EV to Free Cash Flow
39.94 -25.49 -18.89 -33.58 -17.22
EV to Operating Cash Flow
32.07 -62.25 -27.91 -101.33 -24.39
Tangible Book Value Per Share
0.19 0.19 0.20 0.23 0.23
Shareholders’ Equity Per Share
0.23 0.25 0.25 0.28 0.27
Tax and Other Ratios
Effective Tax Rate
-0.32 -0.17 -0.02 -0.03 -0.02
Revenue Per Share
0.24 0.22 0.18 0.17 0.11
Net Income Per Share
>-0.01 -0.01 -0.03 >-0.01 -0.02
Tax Burden
1.32 1.17 1.02 1.03 1.02
Interest Burden
-1.19 1.60 0.89 0.12 1.15
Research & Development to Revenue
0.09 0.11 0.13 0.17 0.21
SG&A to Revenue
0.77 0.79 0.00 0.00 0.00
Stock-Based Compensation to Revenue
-0.01 0.00 0.00 0.04 0.07
Income Quality
-3.45 0.00 0.69 9.53 1.40
Currency in AUD